AgomAb Therapeutics NV American Depositary Shares Long-term Investment Intensity
AgomAb Therapeutics NV American Depositary Shares long-term investment intensity. AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Long-term Investment Intensity of 0.0% as of December 2025. Long-term investments of $11.00K represent 0.0% of total assets of $153.71 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See AgomAb Therapeutics NV American Deposita current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of AgomAb Therapeutics NV American Depositary Shares (2021–2025)
Long-term investment intensity of AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025. This chart shows how AgomAb Therapeutics NV American Depositary Shares's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 0.0%, reflecting long-term investments of $11.00K against total assets of $153.71 Million USD. See operational self-sufficiency of AgomAb Therapeutics NV American Deposita to measure how many days the company can operate on defensive assets alone.
AgomAb Therapeutics NV American Depositary Shares Long-term Investment Intensity by Year (2021–2025)
AgomAb Therapeutics NV American Depositary Shares long-term investment intensity by year from 2021 to 2025. The table below presents the year-by-year Long-term Investment Intensity for AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see AgomAb Therapeutics NV American Deposita (AGMB) total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.0% | $11.00K | $153.71 Million | ▲ +0.0 pp |
| 2024 | 0.0% | $12.00K | $206.36 Million | ▼ 0.0 pp |
| 2023 | 0.0% | $14.00K | $171.26 Million | ▼ 0.0 pp |
| 2022 | 0.0% | $14.00K | $101.00 Million | ▼ -0.2 pp |
| 2021 | 0.2% | $147.00K | $84.00 Million | — |